Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Aquestive Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 46 | 1 | 37 | −8 |
| Shares | 15.9M | 50 | 14.9M | −970.7K (−6.1%) |
| Value | $18.6M | $0 | $13.5M | −$5.13M (−27.6%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Richard W. Paul & Associates, LLC | 1,423 | $1.28K | 0.00% |
| NewSquare Capital LLC | 130 | $117 | 0.00% |
| Coppell Advisory Solutions LLC | 37 | $33 | 0.00% |
| Coppell Advisory Solutions Corp. | 37 | $33 | 0.00% |
Sold out (12)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Goldman Sachs Group Inc | 27,704 | $32.0K |
| Cresset Asset Management, LLC | 26,000 | $30.0K |
| Susquehanna International Group, LLP | 23,850 | $28.0K |
| Mackenzie Financial Corp | 20,318 | $24.0K |
| Royal Bank of Canada | 20,087 | $23.0K |
| Gsa Capital Partners LLP | 13,704 | $16.0K |
| Bayesian Capital Management, LP | 10,235 | $12.0K |
| Running Point Capital Advisors, LLC | 10,000 | $12.0K |
| UBS Group AG | 9,068 | $11.0K |
| Quantbot Technologies LP | 3,751 | $4.00K |
| China Universal Asset Management Co., Ltd. | 499 | $1.00K |
| Citigroup Inc | 410 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Strategic Asset Management, LLC | 50 | $0 |